Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Pharmacological inhibition of 12/15-LOX using agents such as ML351, LOXBlock-1, and BW-B70C significantly reduces infarct volume and mitigates poststroke brain damage (161163)
As a post-approval effort, we can potentially put in liquid-phase alternatives, he said
This endeavor not only has potential as a new therapeutic options for patients but also has enriched our understanding of the underlying mechanisms of epilepsy, advancing the field as a whole
Why it matters
US$ 26.55
US$ 26.29
US$ 21.79
